Computational structure activity relationship studies on the CD1d/Glycolipid/TCR complex using AMBER and AUTODOCK

Journal of Chemical Information and Modeling

Volumn 49, Issue 2, 2009, Pages 410-423

  Nadas, Janos ^a   Li, Chenglong ^a   Wang, Peng George ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBER; LIGANDS; MOLECULAR DYNAMICS; STRUCTURES (BUILT OBJECTS);

AUTODOCK; COMPUTATIONAL STRUCTURE; MOLECULAR DYNAMICS SIMULATIONS; NATURAL KILLER T CELL; RESEARCH FOCUS; STRUCTURE ACTIVITY RELATIONSHIPS;

CRYSTAL STRUCTURE;

CD1D ANTIGEN; GLYCOLIPID; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HYDROGEN BOND; STRUCTURE ACTIVITY RELATION;

ANTIGENS, CD1D; GLYCOLIPIDS; HYDROGEN BONDING; MODELS, MOLECULAR; RECEPTORS, ANTIGEN, T-CELL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 65249142756     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci8002705     Document Type: Article

References (66)

1. Krummel, M. F.; Davis, M. M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 2002, 14, 66-74.
2. Bromley, S. K.; Burack, W. R.; Johnson, K. G.; Somersalo, K.; Sims, T. N.; Sumen, C.; Davis, M. M.; Shaw, A. S.; Allen, P. M.; Dustin, M. L. The immunological synapse. Annu. Rev. Immunol. 2001, 19, 375-396.
3. Gao, G. F.; Jakobsen, B. K. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol. Today 2000, 21, 630-636.
4. Van Kaer, L. a-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 2005, 5, 31-42.
5. Gumperz, J. E. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 2006, 7, 2-13.
6. Gadola, S. D.; Dulphy, N.; Salio, M.; Cerundolo, V. Va24-JaQ-independent, CDld-restricted recognition of a-galactosylceramide by human CD4+ and CD8ab+ T lymphocytes. J. Immunol. 2002, 168, 5514-5520.
7. Martin, L. H.; Calabi, F.; Lefebvre, F. A.; Bilsland, C. A. G.; Milstein, C. Structure and expression of the human thymocyte antigens CDla, CD1b, and CD1c. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 9189-9193.
8. Martin, L. H.; Calabi, F.; Milstein, C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 9154-9158.
9. Calabi, F.; Milstein, C. A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature 1986, 323, 540-543.
10. Calabi, F.; Jarvis, J. M.; Martin, L.; Milstein, C. Two classes of CD1 genes. Eur. J. Immunol. 1989, 19, 285-292.
11. Porcelli, S. A.; Modlin, R. L. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999, 17, 297-329.
12. Brossay, L.; Chioda, M.; Burdin, N.; Koezuka, Y.; Casorati, G.; Dellabona, P.; Kronenberg, M. CD1d-mediated recognition of an a-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 1998, 188, 1521-1528.
13. Parekh, V. V.; Wilson, M. T.; Van Kaer, L. INKT-cell responses to glycolipids. Crit. Rev. Immunol. 2005, 25, 183-213.
14. Kronenberg, M.; Gapin, L. The unconventional lifestyle of NKT Cells. Nat. Rev. Immunol. 2002, 2, 557-568.
15. Natori, T.; Koezuka, Y.; Higa, T. Agelasphins, novel a-galactosylce- ramides from the marine sponge Agelas mauritianus. Tetrahedron Lett. 1993, 34, 5591-5592.
16. Natori, T.; Morita, M.; Akimoto, K.; Koezuka, Y. Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus. Tetrahedron 1994, 50, 2771-2784.
17. Morita, M.; Motoki, K.; Akimoto, K.; Natori, T.; Sakai, T.; Sawa, E.; Yamaji, K.; Koezuka, Y.; Kobayashi, E.; Fukushima, H. Structure-Activity Relationship of a-Galactosylceramides against B16-Bearing Mice. J. Med. Chem. 1995, 38, 2176-2187.
18. Kobayashi, E.; Motoki, K.; Uchida, T.; Fukushima, H.; Koezuka, Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 1995, 7, 529-534.
19. Shimosaka, A. Role of NKT cells and alpha-galactosyl ceramide. Int. J. Hematol. 2002, 76 (Suppl 1), 277-279.
20. Naumov, Y. N.; Bahjat, K. S.; Gausling, R.; Abraham, R.; Exley, M. A.; Koezuka, Y.; Balk, S. B.; Strominger, J. L.; Clare-Salzer, M.; Wilson, S. B. Activation of CDld-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 13838-13843.
21. Taniguchi, M.; Seino, K.-i.; Nakayama, T. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 2003, 4, 1164-1165.
22. Fujio, M.; Wu, D.; Garcia-Navarro, R.; Ho, D. D.; Tsuji, M.; Wong, C.-H. Structure-Based Discovery of Glycolipids for CDld-Mediated NKT Cell Activation: Tuning the Adjuvant versus Immunosuppression Activity. J. Am. Chem. Soc. 2006, 128, 9022-9023.
23. Miyamoto, K.; Miyake, S.; Yamamura, T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001, 413, 531-534.
24. Yu, K. O. A.; Im, J. S.; Molano, A.; Dutronc, Y.; Illarionov, P. A.; Forestier, C.; Fujiwara, N.; Arias, I.; Miyake, S.; Yamamura, T.; Chang, Y.-T.; Besra, G. S.; Porcelli, S. A. Modulation of CDld-restricted NKT cell responses by using N-acyl variants of a-galactosylceramides. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 3383-3388.
25. Corver, J.; Moesby, L.; Erukulla, R. K.; Reddy, K. C.; Bittman, R.; Wilschut, J. Sphingolipid-dependent fusion of Semliki Forest virus with cholesterol-containing liposomes requires both the 3-hydroxyl group and the double bond of the sphingolipid backbone. J. Virol. 1995, 69, 3220-3223.
26. Lang, G. A.; Maltsev, S. D.; Besra, G. S.; Lang, M. L. Presentation of a-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology 2004, 112, 386-396.
27. Rauch, J.; Gumperz, J.; Robinson, C.; Skoeld, M.; Roy, C.; Young, D. C.; Lafleur, M.; Moody, D. B.; Brenner, M. B.; Costello, C. E.; Behar, S. M. Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CDld-restricted Invariant NKT (iNKT) Cell. J. Biol. Chem. 2003, 278, 47508-47515.
28. Zajonc, D. M.; Maricic, I.; Wu, D.; Haider, R.; Roy, K.; Wong, C-H.; Kumar, V.; Wilson, I. A. Structural basis for CDld presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 2005, 202, 1517-1526.
29. Kawano, T.; Cui, J.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Motoki, K.; Ueno, H.; Nakagawa, R.; Sato, H.; Kondo, E.; Koseki, H.; Taniguchi, M. CDld-restricted and TCR-mediated activation of Val4 NKT cells by glycosylceramides. Science 1997, 278, 1626-1629.
30. Iijima, H.; Kimura, K.; Sakai, T.; Uchimura, A.; Shimizu, T.; Ueno, H.; Natori, T.; Koezuka, Y. Structure-activity relationship and conformational analysis of monoglycosylceramides on the syngeneic mixed leukocyte reaction. Bioorg. Med. Chem. 1998, 6, 1905-1910.
31. Zeng, Z. H.; Castano, A. R.; Segelke, B. W.; Stura, E. A.; Peterson, P. A.; Wilson, I. A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997, 277, 339-345.
32. Wu, D.; Xing, G.-W.; Poles, M. A.; Horowitz, A.; Kinjo, Y.; Sullivan, B.; Bodmer-Narkevitch, V.; Plettenburg, O.; Kronenberg, M.; Tsuji, M.; Ho, D. D.; Wong, C.-H. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 1351-1356.
33. Saubermann, L. J.; Beck, P.; De Jong, Y. P.; Pitman, R. S.; Ryan, M. S.; Kim, H. S.; Exley, M.; Snapper, S.; Balk, S. P.; Hagen, S. J.; Kanauchi, O.; Motoki, K.; Sakai, T.; Terhorst, C.; Koezuka, Y.; Podolsky, D. K.; Blumberg, R. S. Activation of natural killer T cells by a-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology 2000, 119, 119-128.
34. Zhou, X.-T.; Forestier, C.; Goff, R. D.; Li, C.; Teyton, L.; Bendelac, A.; Savage, P. B. Synthesis and NKT Cell Stimulating Properties of Fluorophore- and Biotin-Appended 6"-Amino-6"-deoxy-galactosyl-ceramides. Org. Lett. 2002, 4, 1267-1270.
35. Prigozy, T. I.; Naidenko, O.; Qasba, P.; Elewaut, D.; Brossay, L.; Khurana, A.; Natori, T.; Koezuka, Y.; Kulkarni, A.; Kronenberg, M. Glycolipid antigen processing for presentation by CDld molecules. Science 2001, 291, 664-667.
36. Zhou, D.; Mattner, J.; Cantu, C, III.; Schrantz, N.; Yin, N.; Gao, Y.; Sagiv, Y.; Hudspeth, K.; Wu, Y.-P.; Yamashita, T.; Teneberg, S.; Wang, D.; Proia Richard, L.; Levery Steven, B.; Savage Paul, B.; Teyton, L.; Bendelac, A. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306, 1786-1789.
37. Koch, M.; Stronge, V. S.; Shepherd, D.; Gadola, S. D.; Mathew, B.; Ritter, G.; Fersht, A. R.; Besra, G. S.; Schmidt, R. R.; Jones, E. Y.; Cerundolo, V. The crystal structure of human CDld with and without a-galactosylceramide. Nat. Immunol. 2005, 6, 819-826.
38. Wu, D.; Zajonc, D. M.; Fujio, M.; Sullivan, B. A.; Kinjo, Y.; Kronenberg, M.; Wilson, I. A.; Wong, C. H. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CDld. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 3972-3977.
39. Zajonc, D. M.; Savage, P. B.; Bendelac, A.; Wilson, I. A.; Teyton, L. Crystal Structures of Mouse CD1d-iGb3 Complex and its Cognate Val4 T Cell Receptor Suggest a Model for Dual Recognition of Foreign and Self Glycolipids. J. Mol. Biol. 2008, 377, 1104-1116.
40. Gadola, S. D.; Koch, M.; Maries-Wright, J.; Lissin, N. M.; Shepherd, D.; Matulis, G.; Harlos, K.; Villiger, P. M.; Stuart, D. I.; Jakobsen, B. K.; Cerundolo, V.; Jones, E. Y. Structure and binding kinetics of three different human CDld-a-galactosylceramide-specific T cell receptors. J. Exp. Med. 2006, 203, 699-710.
41. Kjer-Nielsen, L.; Borg, N. A.; Pellicci, D. G.; Beddoe, T.; Kostenko, L.; Clements, C. S.; Williamson, N. A.; Smyth, M. J.; Besra, G. S.; Reid, H. H.; Bharadwaj, M.; Godfrey, D. I.; Rossjohn, J.; McCluskey, J. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 2006, 203, 661-673.
42. Borg, N. A.; Wun, K. S.; Kjer-Nielsen, L.; Wilce, M. C. J.; Pellicci, D. G.; Koh, R.; Besra, G. S.; Bharadwaj, M.; Godfrey, D. I.; McCluskey, J.; Rossjohn, J. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007, 448, 44-49.
43. Pearlman, D. A.; Case, D. A.; Caldwell, J. W.; Ross, W. S.; Cheatham, T. E., III.; DeBolt, S.; Ferguson, D.; Seibel, G.; Kollman, P. \"AMBER\", a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to stimulate the structural and energetic properties of molecules. Comput. Phys. Commun. 1995, 91, 1-42.
44. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19, 1639-1662.
45. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, E. F., Jr.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 1977, 112, 535-542.
46. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926-935.
47. Pellegrini, E.; Field, M. J. A Generalized-Born Solvation Model for Macromolecular Hybrid-Potential Calculations. J. Phys. Chem. A 2002, 106, 1316-1326.
48. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 2003, 24, 1999-2012.
49. Woods, R. J.; Dwek, R. A.; Edge, C. J.; Fraser-Reid, B. Molecular Mechanical and Molecular Dynamic Simulations of Glycoproteins and Oligosaccharides. 1. GLYCAM-93 Parameter Development. J. Phys. Chem. 1995, 99, 3832-3846.
50. Wang, J.; Wang, W.; Kollman, P. A.; Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graphics Modell. 2006, 25, 247-260.
51. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a general Amber force field. J. Comput. Chem. 2004, 25, 1157-1174.
52. MacroModel, version 8.5; Schrödinger Inc.: Portland, OR, 2003.
53. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semi-analytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
54. Jorgensen, W. L.; Tirado-Rives, J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 1988, 110, 1657-1666.
55. Guex, N.; Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer. An environment for comparative protein modeling. Electrophoresis 1997, 18, 2714-2723.
56. Wun, K. S.; Borg, N. A.; Kjer-Nielsen, L.; Beddoe, T.; Koh, R.; Richardson, S. K.; Thakur, M.; Howell, A. R.; Scott-Browne, J. P.; Gapin, L.; Godfrey, D. I.; McCluskey, J.; Rossjohn, J. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 2008, 205, 939-949.
57. Savage, P. B.; Teyton, L.; Bendelac, A. Glycolipids for natural killer T cells. Chem. Soc. Rev. 2006, 35, 771-119.
58. Sakai, T.; Naidenko, O. V.; Iijima, H.; Kronenberg, M.; Koezuka, Y. Syntheses of Biotinylated a-Galactosylceramides and Their Effects on the Immune System and CD1 Molecules. J. Med. Chem. 1999, 42, 1836-1841.
59. Kawano, T.; Cui, J.; Koezuka, Y.; Toura, I.; Kaneko, Y.; Motoki, K.; Ueno, H.; Nakagawa, R.; Sato, H.; Kondo, E.; Koseki, H.; Taniguchi, M. CD1d-restricted and TCR-mediated activation of valphal4 NKT cells by glycosylceramides. Science 1997, 278, 1626-1629.
60. Kinjo, Y.; Wu, D.; Kim, G.; Xing, G.-W.; Poles, M. A.; Ho, D. D.; Tsuji, M.; Kawahara, K.; Wong, C.-H.; Kronenberg, M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434, 520-525.
61. Cantu, C, III.; Benlagha, K.; Savage, P. B.; Bendelac, A.; Teyton, L. The Paradox of Immune Molecular Recognition of a-Galactosylce-ramide: Low Affinity, Low Specificity for CDld, High Affinity for ab TCRs. J. Immunol. 2003, 170, 4673-4682.
62. Sidobre, S.; Hammond, K. J. L.; Benazet-Sidobre, L.; Maltsev, S. D.; Richardson, S. K.; Ndonye, R. M.; Howell, A. R.; Sakai, T.; Besra, G. S.; Porcelli, S. A.; Kronenberg, M. The T cell antigen receptor expressed by Val4i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12254-12259.
63. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W., Jr.; Murphy, W. J.; Wiltrout, R. H. Dissociation of NKT Stimulation, Cytokine Induction, and NK Activation In Vivo by the Use of Distinct TCR-Binding Ceramides. J. Immunol. 2004, 172, 943-953.
64. Stanic, A. K.; De Silva, A. D.; Park, J.-J.; Sriram, V.; Ichikawa, S.; Hirabyashi, Y.; Hayakawa, K.; Van Kaer, L.; Brutkiewicz, R. R.; Joyce, S. Defective presentation of the CD1d1-restricted natural Val4Jal8 NKT lymphocyte antigen caused by b-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1849-1854.
65. Long, X.; Deng, S.; Mattner, J.; Zang, Z.; Zhou, D.; McNary, N.; Goff, R. D.; Teyton, L.; Bendelac, A.; Savage, P. B. Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids. Nat. Chem. Biol. 2007, 3, 559-564.
66. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25, 1605-1612.